中国国家医保局通报了河北医科大学第二医院发生的重大腐败案件1。超过30家医药企业在长达11年的时间内向该医院工作人员进行商业贿赂，累计涉案金额达人民币1.84亿元1。医院工作人员共收受贿赂46次，其中单次最大涉案金额达1658万元1。
这起案件涉及医疗耗材和药物等30多种医用产品1。河北祥恩医疗器械贸易有限公司累计向医院工作人员行贿2064万元，是涉案金额最大的企业1。据通报，医药企业采取的贿赂手段包括按医疗器材单位收取回扣，如"每条支架收5000元回扣"等方式1。截至2025年下半年，该案已涉及9件司法刑事判决，其中11家企业因行贿罪被起诉1。医保部门指出，该案反映了医药购销领域存在的严重腐败问题1。
China's National Healthcare Security Administration has exposed an extensive corruption scheme at Hebei Medical University Second Hospital, where more than 30 pharmaceutical companies systematically bribed hospital staff over eleven years, accumulating a total of 184 million yuan in illicit payments, equivalent to approximately 860 million New Taiwan dollars.1 The hospital's personnel accepted commercial bribes on 46 separate occasions involving over 30 types of medical products, including artificial intraocular lenses and drug-eluting stent systems.1 The case represents a critical instance of serious corruption within the medical and pharmaceutical procurement sector, as acknowledged by healthcare officials.1
The investigation revealed substantial individual transactions within the broader scheme. A single case involved 16.58 million yuan in bribes, while Hebei Xiangen Medical Device Trading Company alone transferred 20.64 million yuan to hospital personnel.1 In one documented instance, hospital staff received 5,000 yuan in kickbacks per stent unit.1 The scandal prompted nine criminal judgments related to the hospital in the second half of 2025, and eleven enterprises faced charges of commercial bribery.1
评论
还没有评论，欢迎留下第一条。